Clear Street Launches Healthcare & Biotechnology Equity Research

BusinesswireDec 18 03:00

Bristol Myers Squibb Terminates Agreements With Immatics Due To Ongoing Portfolio Prioritization Efforts Within BMS For Allogeneic Programs; Collaboration With BMS Under The 2019 Multi-Target TCR-T Strategic Collaboration Agreement Remains Ongoing

BenzingaDec 16 22:42

Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $16

Futu NewsDec 16 19:31 · Ratings

Immatics N.V. Reports Strong Q3 2024 Progress and Financials

TipRanksNov 26 11:57

Goldman Sachs Initiates Immatics(IMTX.US) With Buy Rating, Announces Target Price $13.5

Futu NewsNov 26 06:31 · Ratings

Earnings Update: Immatics N.V. (NASDAQ:IMTX) Just Reported And Analysts Are Boosting Their Estimates

Simply Wall StNov 20 20:00